[Bisphosphonate associated osteonecrosis of the jaws--the role of the dentist in prevention and early diagnosis].
During the past few years numerous cases of osteonecrosis of the jaws in patients receiving bisphosphonate therapy were published in the literature. In most cases, the osteonecrosis was diagnosed following dento-alveolar surgery, especially following extraction of teeth. To date, no efficient therapy is available and most efforts are geared towards prevention. The propose of the present review is to inform the Israeli dental community about osteonecrosis of the jaws in patients receiving bisphosphonate therapy and to suggest strategies for prevention.
Yarom
N
N
Oral Medicine Clinic, Department of Oral and Maxillofacial Surgery, The Chaim Sheba Medical Center, Tel Hashomer, Israel.
Rachima
H
H
Yahalom
R
R
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D003815:Dentists; D004164:Diphosphonates / Q000009:adverse effects*; D042241:Early Diagnosis; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D024382:Professional Role
D050071:Bone Density Conservation Agents; D004164:Diphosphonates